Literature DB >> 33712004

Improving seasonal influenza vaccination for older adults.

Graham Pawelec1,2, Janet McElhaney3.   

Abstract

Entities:  

Year:  2021        PMID： 33712004      PMCID： PMC7952500          DOI： 10.1186/s12979-021-00224-1

Source DB:  PubMed          Journal:  Immun Ageing        ISSN： 1742-4933            Impact factor:   6.400


× No keyword cloud information.
  6 in total

1.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

2.  Cellular immune correlates of protection against symptomatic pandemic influenza.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Katja Hoschler; Walt Adamson; William Carman; Thomas Bean; Wendy Barclay; Jonathan J Deeks; Ajit Lalvani
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

3.  Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma.

Authors:  Henning Zelba; Benjamin Weide; Alexander Martens; Evelyna Derhovanessian; Jithendra Kini Bailur; Christina Kyzirakos; Annette Pflugfelder; Thomas K Eigentler; Anna Maria Di Giacomo; Michele Maio; Erik H J G Aarntzen; Jolanda de Vries; Antje Sucker; Dirk Schadendorf; Petra Büttner; Claus Garbe; Graham Pawelec
Journal:  Clin Cancer Res       Date:  2014-06-17       Impact factor: 12.531

4.  Collateral benefits on other respiratory infections during fighting COVID-19.

Authors:  Khee-Siang Chan; Fu-Wen Liang; Hung-Jen Tang; Han Siong Toh; Wen-Liang Yu
Journal:  Med Clin (Barc)       Date:  2020-06-05       Impact factor: 1.725

5.  Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults.

Authors:  Athena P Y Li; Carolyn A Cohen; Nancy H L Leung; Vicky J Fang; Shivaprakash Gangappa; Suryaprakash Sambhara; Min Z Levine; A Danielle Iuliano; Ranawaka A P M Perera; Dennis K M Ip; J S Malik Peiris; Mark G Thompson; Benjamin J Cowling; Sophie A Valkenburg
Journal:  NPJ Vaccines       Date:  2021-02-16       Impact factor: 9.399

6.  Unanticipated efficacy of SARS-CoV-2 vaccination in older adults.

Authors:  Graham Pawelec; Janet McElhaney
Journal:  Immun Ageing       Date:  2021-02-17       Impact factor: 6.400
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.